Calypso Biotech SA
Calypso Biotech, a Dutch company developing treatments for autoimmune diseases was acquired by Novartis in January 2024.
1
Funding Rounds
$22.7m
Money raised
Overview
Calypso Biotech, a Dutch company developing treatments for autoimmune diseases was acquired by Novartis in January 2024.
- Website:
- Business model: B2C
- Social accounts: linkedin
Industries
Calypso Biotech SA is active in the following industries: